BioCentury
ARTICLE | Company News

Message, Aventis in gene expression deal

March 19, 2001 8:00 AM UTC

Message (Malvern, Penn.) will use its Specific Control of RNA Interaction and Binding Events (SCRIBE) technology to study post-transcriptional regulatory mechanisms of gene expression associated with ...